← Back to Discover
ACORN CAPITAL ADVISORS, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $366,457,132
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CG ONCOLOGY INC · COM · 156944100 · shares: $80,393,115
- UROGEN PHARMA LTD · COM · M96088105 · shares: $61,581,856
- TREVI THERAPEUTICS INC · COM · 89532M101 · shares: $40,001,341
- CANDEL THERAPEUTICS INC · COM · 137404109 · shares: $36,028,864
- PUMA BIOTECHNOLOGY INC · COM · 74587V107 · shares: $33,504,835
- JADE BIOSCEINCES INC · COM NEW · 008064206 · shares: $21,925,807
- BICARA THERAPEUTICS · COM · 055477103 · shares: $19,102,000
- KARYOPHARM THERAPEUTICS INC · COMMON STOCK · 48576U205 · shares: $14,831,964
- ONKURE THERAPEUTICS INC · CLASS A COM · 68277Q105 · shares: $12,948,913
- HELUS PHARMA INC. · COM STK · 23256X407 · shares: $10,181,159
Reported holdings
20 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CG ONCOLOGY INC | COM | 156944100 | — | 1,131,500 shares | $80,393,115 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 1,673,420 shares | $61,581,856 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 2,144,844 shares | $40,001,341 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 3,497,948 shares | $36,028,864 |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | — | 4,131,299 shares | $33,504,835 |
| JADE BIOSCEINCES INC | COM NEW | 008064206 | — | 986,760 shares | $21,925,807 |
| BICARA THERAPEUTICS | COM | 055477103 | — | 643,381 shares | $19,102,000 |
| KARYOPHARM THERAPEUTICS INC | COMMON STOCK | 48576U205 | — | 1,518,113 shares | $14,831,964 |
| ONKURE THERAPEUTICS INC | CLASS A COM | 68277Q105 | — | 2,839,674 shares | $12,948,913 |
| HELUS PHARMA INC. | COM STK | 23256X407 | — | 1,540,266 shares | $10,181,159 |
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | — | 1,752,115 shares | $6,693,079 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 929,077 shares | $6,596,447 |
| LEONABIO, INC. | COMMON STOCK | 04746L203 | — | 634,539 shares | $5,831,413 |
| VERASTEM INC | COM | 92337C203 | — | 1,469,153 shares | $5,612,164 |
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | — | 1,139,363 shares | $5,218,283 |
| Q32 BIO INC. | COM | 746964105 | — | 216,171 shares | $2,754,019 |
| EUGENE THERAPEUTICS | COM | 29286X101 | — | 1,271,257 shares | $2,199,275 |
| JASPER THERAPEUTICS | COM | 471871202 | — | 1,438,159 shares | $604,027 |
| BIOATLA INC | COM | 09077B104 | — | 108,126 shares | $447,645 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 1,425 shares | $926 |